The 26 cancer drugs mainly target CYP proteins, SLC carriers, ATP transporters, and UDP-glucuronosyltransferases, which are mainly found in the eight following pathways: androgen and estrogen synthesis and metabolism, arachidonic acid metabolism, bile acid synthesis, cytochrome metabolism, drug metabolism, linoleate metabolism, steroid metabolism, transport, and extracellular pathways. The gene discussed is B3GAT2; the disease is cancer.